NeuroGyn AG is developing new innovative solutions in the domain of neurotechnology for the international medical markets with the mission to improve the quality of life for hundreds of millions of patients. NeuroGyn’s products are the result of modern R&D based on the latest findings in the Neuropelveology & Women Health. NeuroGyn has the US-patent right on laparoscopic (LION procedures) and vaginal implantation (GNS-therapy) of neuroprothesis to the pelvic nerves with corresponding indications. The clinical effectiveness of these therapies no longer needs to be proven but requires the development of an appropriate neuroprothesis. This neuroprothesis bases on requirements for clinicians and is designed for both the LION and GNS procedures. NeuroGyn holds the international/EU/US licensing rights for own neuroprothesis and surgical „applicators“.